Ca
Capsida Bio
Thousand Oaks CAFounded 2019100 employees
Private CapbiotechPrivateGenetic Medicine
Platform: AAV Engineered
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CAP-2067 | CAP-2067 | Phase 2/3 | 2 | JAK2 | Melanoma | ||
| CAP-150 | CAP-150 | NDA/BLA | 1 | PI3Kα | MGALL |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (2)